Visit The Supreme Cannabis Company Investor Dashboard and stay up to date with data-driven, fact based due diligence for active traders and investors.
Supreme Crosses Important Revenue Milestone
TORONTO, Oct. 3, 2017 /CNW/ – Supreme Pharmaceuticals Inc. (“Supreme” or the “Company”) (TSXV: FIRE) (OTC: SPRWF) is pleased to announce that 7ACRES’ first month of sales exceeded $1,500,000, and that such sales will be recorded in the quarter ended September 30, 2017.
“Our first sales represent a significant milestone for Supreme and demonstrate our ability to cultivate premium cannabis, navigate the regulatory process, and deliver commercial quantities of a high-quality product to our retail partners. Our first sales offer additional validation of our ability to execute on our unique, scalable and focused business model,” said John Fowler, CEO of Supreme.
7ACRES is establishing a new premium product segment in the Canadian ACMPR industry. Our innovative Hybrid Facility combines the technology of indoor cultivation with the quality of full spectrum sunlight to produce cannabis targeted at the premium segment of the market. Our passionate team is committed to maintaining our quality standards as we scale our cultivation.
John Fowler, CEO of Supreme
For Supreme, SunGrown is not about low cost. SunGrown is a premium product category produced by combining the science of indoor cultivation and the sun to produce beautiful terpene-rich cannabis.
As the leading business-to-business (“B2B”) focused Licensed Producer in Canada, Supreme is working toward establishing a standard for B2B cannabis transactions. Due to the rigorous regulatory oversight of legal cannabis markets, large commercial B2B transactions require intensive due diligence. Supreme requires active and potential clients to participate in an industry-leading B2B due diligence process including chemical analysis, pesticide testing, physical inspection and a thorough inspection of the 7ACRES Hybrid Facility.
Supreme is a Canadian publicly traded company committed to becoming a leading cultivator and distributor of sun grown cannabis through its wholly-owned subsidiary 7ACRES. 7ACRES is a federally licensed producer of medical cannabis pursuant to the ACMPR operating inside a 342,000 sq. ft. Hybrid Greenhouse Facility. The Hybrid Greenhouse Facility combines the best technology of indoor production with the efficiencies and sustainability of a greenhouse, in a single large-format production footprint. Please visit www.supreme.ca and www.7acres.com for more information.
Original press release: http://www.newswire.ca/news-releases/supreme-crosses-important-revenue-milestone-649208423.html
For fact-based information on The Supreme Cannabis Company, view the company’s sponsored Investor Dashboard.
Get ahead of the crowd by signing up for 420 Investor, the largest & most comprehensive premium subscription service for cannabis traders and investors since 2013.